Dengue fever: Diagnosis and treatment

Expert Review of Anti-Infective Therapy

Volumn 8, Issue 7, 2010, Pages 841-845

  Wiwanitkit, Viroj ^a  

^a WIWANITKIT HOUSE   (Thailand)

Author keywords

Dengue; Diagnosis; Treatment

Indexed keywords

ADENOSINE DERIVATIVE; ANTIVIRUS AGENT; AZAURIDINE; GLYCYRRHIZIC ACID; NITD 008; POLYSACCHARIDE; RIBAVIRIN; UNCLASSIFIED DRUG;

AEDES AEGYPTI; ANAMNESIS; BLEEDING; CLINICAL FEATURE; DENGUE; DENGUE VIRUS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; FEVER; FLUID THERAPY; HEADACHE; HEMOSTASIS; HUMAN; MALAISE; MOLECULAR DIAGNOSIS; MYALGIA; NONHUMAN; PATHOGENESIS; POINT OF CARE TESTING; REVIEW; SERODIAGNOSIS; THROMBOCYTOPENIA;

ANTIVIRAL AGENTS; DENGUE; DENGUE VIRUS; DIAGNOSIS, DIFFERENTIAL; FLUID THERAPY; HUMANS; RNA, VIRAL;

EID: 77954231486     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.10.53     Document Type: Review

References (59)

1. Menard B. Geographic changes in exposure to dengue. Sante 13, 89-94 (2003).
2. Pinheiro FP, Corber SJ. Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas. World Health Stat. Q. 50, 161-169 (1997).
3. Shah I, Deshpande GC, Tardeja PN. Outbreak of dengue in Mumbai and predictive markers for dengue shock syndrome. J. Trop. Pediatr. 50, 301-305 (2004).
4. Zhoa Z. Current status in the prevention and control of dengue fever in China. Zhonghua Liu Xing Bing Xue Za Zhi 21, 223-224 (2000).
5. Luo H, He J, Zheng K, Li L, Jiang L. Analysis on the epidemiologic features of Dengue fever in Guangdong province, 1990-2000. Zhonghua Liu Xing Bing Xue Za Zhi 23, 427-430 (2002).
6. Russell RC, Dwyer DE. Arboviruses associated with human disease in Australia. Microbes Infect. 2, 1693-1704 (2000).
7. Hills SL, Piispanen JP, Humphreys JL, Foley PN. A focal, rapidly controlled outbreak of dengue fever in two suburbs in Townsville, North Queensland, 2001. Commun. Dis. Intell. 26, 596-600 (2001).
8. Malcolm RL, Hanna JN, Phillips DA. The timeliness of notification of clinically suspected cases of dengue imported into north Queensland. Aust. NZ J. Public Health 23, 414-417 (1999).
9. DeHart RL. Health issues of air travel. Annu. Rev. Public Health 24, 133-151 (2003).
10. Reiskind MH, Baisley KJ, Calampa C, Sharp TW, Watts DM, Wilson ML. Epidemiological and ecological characteristics of past dengue virus infection in Santa Clara, Peru. Trop. Med. Int. Health 6, 212-218 (2001).
11. Vaughn DW. Invited commentary: dengue lessons from Cuba. Am. J. Epidemiol. 152, 800-803 (2000).
12. Haas W, Krause G, Marcus U, Stark K, Ammon A, Burger R. "Emerging infectious diseases": dengue-fever, West-Nile-fever, SARS, avian influenza, HIV." Internist. (Berlin) 45, 684-692 (2004).
13. Badiaga S, Barrau K, Brouqui P et al. Infectio-Sud Group. Imported dengue in French university hospitals: a 6-year survey. J. Travel Med. 10, 286-289 (2003).
14. Gascon J, Giner V, Vidal J, Jou JM, Mas E, Corachan M. Dengue: a re-emerging disease. A clinical and epidemiological study in 57 Spanish travelers. Med. Clin. (Barc.) 111, 583-586 (1998).
15. Fagbami AH, Monath TP, Fabiyi A. Dengue virus infections in Nigeria: a survey for antibodies in monkeys and humans. Trans. R. Soc. Trop. Med. Hyg. 71, 60-65 (1977).
16. Gubler DJ, Sather GE, Kuno G, Cabral JR. Dengue 3 virus transmission in Africa. Am. J. Trop. Med. Hyg. 35, 1280-1284 (1986).
17. Rodier GR, Parra JP, Kamil M, Chakib SO, Cope SE. Recurrence and emergence of infectious diseases in Djibouti city. Bull. World Health Organ. 73, 755-759 (1995).
18. Barboza P, Tarantola A, Lassel L, Mollet T, Quatresous I, Paquet C. Emerging viral infections in South East Asia and the Pacific region. Med. Mal. Infect. 38, 513-523 (2008).
19. Pinheiro FP, Corber SJ. Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas. World Health Stat. Q. 50, 161-169 (1997).
20. Degallier N, Herve JP, Travassos da Rosa AP, Sa GC. Aedes aegypti (L.): importance of its bioecology in the transmission of dengue and other arboviruses. I Bull. Soc. Pathol. Exot. Filiales 81, 97-110 (1988).
21. Mitrakul C. Bleeding problem in dengue haemorrhagic fever: platelets and coagulation changes. Southeast Asian J. Trop. Med. Public Health 18, 407-412 (1987).
22. Falconar AK. Dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Arch. Virol. 142, 897-916 (1997).
23. Wang S, He R, Patarapotikul J, Innis BL, Anderson R. Antibody-enhanced binding of dengue-2 virus to human platelets. Virology 213, 254-257 (1995).
24. Wiwanitkit V. Dengue virus nonstructural-1 protein and its phylogenetic correlation to human fibrinogen and thrombocytes: a study to explain hemorrhagic complication. Int. J. Genom. Proteomics 1, 2 (2004).
25. Wiwanitkit V. Platelet CD61 might have an important role in causing hemorrhagic complication in dengue infection. Clin. Appl. Thromb. Hemost. 11, 112 (2005).
26. Wiwanitkit V. A study on functional similarity between dengue non structural protein 1 and platelet integrin/adhesin protein, CD61. J. Ayub. Med. Coll. Abbottabad. 18, 13-16 (2006).
27. Wiwanitkit V. Weak binding affinity of immunoglobin G, an explanation for the immune mimicking theory in pathophysiologic findings in the recovery phase of dengue. Nanomedicine 1, 239-240 (2005).
28. Wiwanitkit V. Bleeding and other presentations in Thai patients with dengue infection. Clin. Appl. Thromb. Hemost. 10, 397-398 (2004).
29. Guzman MG, Kouri G. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J. Clin. Virol. 27, 1-13 (2003).
30. Guzman MG, Kouri G. Dengue: an update. Lancet Infect. Dis. 2, 33-42 (2002).
31. da Fonseca BA, Fonseca SN. Dengue virus infections. Curr. Opin. Pediatr. 14, 67-71 (2002).
32. Wiwanitkit V. Magnitude and pattern of pulmonary pathology in fatal cases of dengue hemorrhagic fever in Thailand. Int. J. Tuberc. Lung Dis. 9, 1060 (2005). (Pubitemid 41549200)
33. Wiwanitkit V. The tourniquet test is still a good screening tool for dengue illness. Trop. Doct. 35, 127-128 (2005).
34. Cao X T, Ngo TN, Wills B et al. Paediatric Hospital Study Group. Evaluation of the World Health Organization standard tourniquet test and a modified tourniquet test in the diagnosis of dengue infection in Vietnam. Trop. Med. Int. Health 7, 125-132 (2002).
35. Kowitdamrong E, Thammaborvorn R, Semboonlor L, Mungmee V, Bhattarakosol P. Detection of dengue HI and IgM antibody: is it diagnostically useful? When and how? J. Med. Assoc. Thai 84(Suppl. 1), S148-S154 (2001).
36. Schilling S, Ludolfs D, Van An L, Schmitz H. Laboratory diagnosis of primary and secondary dengue infection. J. Clin. Virol. 31, 179-184 (2004).
37. Conceição TM, Da Poian AT, Sorgine MH. A real-time PCR procedure for detection of dengue virus serotypes 1, 2, and 3, and their quantitation in clinical and laboratory samples. J. Virol. Methods 163, 1-9 (2010).
38. De Paula SO, Fonseca BA. Dengue: a review of the laboratory tests a clinician must know to achieve a correct diagnosis. Braz. J. Infect. Dis. 8, 390-398 (2004).
39. De Paula SO, Lopes da Fonseca BA. Optimizing dengue diagnosis by RT-PCR in IgM-positive samples: comparison of whole blood, buffy-coat and serum as clinical samples. J. Virol. Methods 102, 113-117 (2002).
40. Teles FR, Prazeres DM, Lima-Filho JL. Trends in dengue diagnosis. Rev. Med. Virol. 15, 287-302 (2005).
41. Guzmán MG, Kourí G. Dengue diagnosis, advances and challenges. Int. J. Infect. Dis. 8, 69-80 (2004).
42. Peyrefitte CN, Pastorino B, Bessaud M, Tolou HJ, Couissinier-Paris P. Evidence for in vitro falsely-primed cDNAs that prevent specific detection of virus negative strand RNAs in dengue-infected cells: improvement by tagged RT-PCR. J. Virol. Methods 113, 19-28 (2003).
43. Yang S, Rothman RE. PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings. Lancet Infect. Dis. 4, 337-348 (2004).
44. Wiwanitkit V. Nanomedicine: diagnosis to therapy. Asian Pac. J. Trop. Med. 1, 68-70 (2008).
45. Lee YF, Lien KY, Lei HY, Lee GB. An integrated microfluidic system for rapid diagnosis of dengue virus infection. Biosens. Bioelectron. 25, 745-752 (2009).
46. Park SM, Huh YS, Craighead HG, Erickson D. A method for nanofluidic device prototyping using elastomeric collapse. Proc. Natl Acad. Sci. USA 106, 15549-15554 (2009).
47. Lien KY, Lee WC, Lei HY, Lee GB. Integrated reverse transcription polymerase chain reaction systems for virus detection. Biosens. Bioelectron. 22, 1739-1748 (2007).
48. Misiano DR, Meyerhoff ME, Collison M. Current and future directions in the technology relating to bedside testing of critically ill patients. Chest 97(5 Suppl.), S204-S214 (1990).
49. Huang JL, Huang JH, Shyu RH et al. High-level expression of recombinant dengue viral NS-1 protein and its potential use as a diagnostic antigen. J. Med. Virol. 65, 553-560 (2001).
50. Wu TZ, Su CC, Chen LK, Yang HH, Tai DF, Peng KC. Piezoelectric immunochip for the detection of dengue fever in viremia phase. Biosens. Bioelectron. 15, 689-695 (2005).
51. Soni A, Chugh K, Sachdev A, Gupta D. Management of dengue fever in ICU. Indian J. Pediatr. 68, 1051-1055 (2001).
52. Ngo NT, Cao XT, Kneen R et al. Acute management of dengue shock syndrome: a randomized double-blind comparison of 4 intravenous fluid regimens in the first hour. Clin. Infect. Dis. 32, 204-213 (2001).
53. Damonte EB, Matulewicz MC, Cerezo AS. Sulfated seaweed polysaccharides as antiviral agents. Curr. Med. Chem. 11, 2399-2419 (2004).
54. Crance JM, Scaramozzino N, Jouan A, Garin D. Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses. Antiviral Res. 58, 73-79 (2003).
55. Yin Z, Chen YL, Schul W et al. An adenosine nucleoside inhibitor of dengue virus. Proc. Natl Acad. Sci. USA 106, 20435-20439 (2009).
56. Lescar J, Luo D, Xu T et al. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from dengue virus as a target. Antiviral Res. 80, 94-101 (2008).
57. Frecer V, Miertus S. Design, structure-based focusing and in silico screening of combinatorial library of peptidomimetic inhibitors of dengue virus NS2B-NS3 protease. J. Comput. Aided Mol. Des. 24(3), 195-212 (2010).
58. Che P, Wang L, Li Q. The development, optimization and validation of an assay for high throughput antiviral drug screening against dengue virus. Int. J. Clin. Exp. Med. 8, 363-373 (2009).
59. WHO. Dengue - guidelines for diagnosis, treatment, prevention and control - new edition, 2009 http://whqlibdoc.who.int/publications/ 2009/9789241547871- eng.pdf